Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation.
Sung E, Ko M, Won JY, Jo Y, Park E, Kim H, Choi E, Jung UJ, Jeon J, Kim Y, Ahn H, Choi DS, Choi S, Hong Y, Park H, Lee H, Son YG, Park K, Won J, Oh SJ, Lee S, Kim KP, Yoo C, Song HK, Jin HS, Jung J, Park Y. Sung E, et al. Among authors: jin hs. Mol Ther. 2022 Aug 3;30(8):2800-2816. doi: 10.1016/j.ymthe.2022.05.003. Epub 2022 May 6. Mol Ther. 2022. PMID: 35526096 Free PMC article.
The ubiquitin system in immune regulation.
Park Y, Jin HS, Aki D, Lee J, Liu YC. Park Y, et al. Among authors: jin hs. Adv Immunol. 2014;124:17-66. doi: 10.1016/B978-0-12-800147-9.00002-9. Adv Immunol. 2014. PMID: 25175772 Review.
CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy.
Jin HS, Ko M, Choi DS, Kim JH, Lee DH, Kang SH, Kim I, Lee HJ, Choi EK, Kim KP, Yoo C, Park Y. Jin HS, et al. Cancer Immunol Res. 2020 Jul;8(7):912-925. doi: 10.1158/2326-6066.CIR-19-0877. Epub 2020 Apr 7. Cancer Immunol Res. 2020. PMID: 32265229
Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis.
Yoo C, Lee SS, Song KB, Jeong JH, Hyung J, Park DH, Song TJ, Seo DW, Lee SK, Kim MH, Lee SS, Kim JH, Jin HS, Park JH, Hwang DW, Lee JH, Lee W, Chang HM, Kim KP, Ryoo BY, Kim SC. Yoo C, et al. Among authors: jin hs. Br J Cancer. 2020 Aug;123(3):362-368. doi: 10.1038/s41416-020-0867-x. Epub 2020 May 20. Br J Cancer. 2020. PMID: 32433600 Free PMC article. Clinical Trial.
TIGIT/CD226 Axis Regulates Anti-Tumor Immunity.
Yeo J, Ko M, Lee DH, Park Y, Jin HS. Yeo J, et al. Among authors: jin hs. Pharmaceuticals (Basel). 2021 Feb 28;14(3):200. doi: 10.3390/ph14030200. Pharmaceuticals (Basel). 2021. PMID: 33670993 Free PMC article. Review.
Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy.
Lee DH, Choi S, Park Y, Jin HS. Lee DH, et al. Among authors: jin hs. Pharmaceuticals (Basel). 2021 Oct 17;14(10):1053. doi: 10.3390/ph14101053. Pharmaceuticals (Basel). 2021. PMID: 34681277 Free PMC article. Review.
242 results